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The genus Candida includes approximately 200 species and about 
20 of them are known as potential human pathogens. In the ‘80s most 
infections were caused by Candida albicans, but from the ‘90s to present a 
significant epidemiological change was observed. The majority of the 
infections are still attributed to C. albicans, however, the number of cases 
caused by non-albicans Candida species (NAC) such as C. parapsilosis, C. 
glabrata, C. krusei, C. tropicalis, C. guilliermondii and C. lusitaniae is 
rising. Until the ‘90s NAC species represented 10-40% of all reported 
candidaemias, but between 1991 and 1998 this proportion grew up to 35-
60% of the total number of cases studied. 
The epidemiological change might have happened due to the 
extended use of fluconazole, against which C. krusei has primary, while C. 
glabrata shows secondary resistance. The virulence of the NAC species is 
generally lower than that of C. albicans but the infections caused by them 
can result in up to 70% mortality due to their resistance to antifungal drugs. 
The emergence of non-albicans Candida species as human pathogens might 
be the consequence of the increased number of surgical inventions, the 
extended use of chemotherapeutic agents and the growing number of HIV 
infected patients. Along with these changes, the development of diagnostic 
methods can also lead to the increase of identified infections caused by 
NAC species.  
In the case of Candida infections the treatment generally starts with 
the use of amphotericin B and/or fluconazole. The proper identification of 
the causative Candida species is crucial in selecting the appropriate 
antifungal agent due to the differences in the antifungal susceptibilities of 
the different species. The fact that certain Candida species are originally 
insensitive or they are able to develop resistance quickly to the most 
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commonly used antifungal drugs, such as fluconazole or amphotericin B, 
makes finding the proper means of therapy even more difficult. 
 
AIMS OF THE WORK 
The number of infections caused by non-albicans Candida species has 
increased substantially during the past decades. The different Candida 
species can have different susceptibility profiles to antifungal drugs, 
therefore the identification of the causative agent of the infection at the 
species level is crucial in order to find the proper means of therapy. 
Therefore the following aims were addressed in our work: 
1. The development of a PCR based method for the efficient 
identification of eight clinically important Candida species: C. 
albicans, C. dubliniensis, C. glabrata, C. parapsilosis, C. 
tropicalis, C. krusei, C. guilliermondii and C. lusitaniae. 
2. The investigation of the occurrence and genetic variability of 
clinical isolates of C. parapsilosis in Hungary. 
3. The examination of the effect of interactions between antifungal 





Classical microbiological methods: 
 Maintenance of the strains 
 Carbohydrate assimilation tests 
 In vitro antifungal susceptibility tests by using microdilution 
method 
 In vitro antifungal susceptibility tests by using the E-test method 
 Examination of the interactions between antifungal agents and 
statins by using the checkerboard titration method 
DNA based techniques: 
 DNA extraction 
 Polymerase chain reaction (PCR, multiplex PCR) 
 DNS sequencing 
 RAPD analysis 
Analysis of the nucleotide sequence data: 
 Identification based on sequence data (BLAST) 
 Alignment of the nucleotide sequences (CLUSTALX) 
 Phylogenetic analysis 




Development of a PCR-based assay for the detection of human 
pathogenic Candida species (Beszedics et al., 2008) 
 
We developed a rapid PCR-based method that allowed us to 
identify the most frequent human pathogenic Candida species. The first 
group of the reactions is based on the amplification of part of the rDNA 
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complex. With these reactions we were able to detect and identify eight 
Candida species: C. krusei, C. guilliermondii, C. lusitaniae, C. glabrata C. 
albicans, C. dubliniensis C. tropicalis and C. parpapsilosis sensu lato. Our 
aim was to design a multiplex PCR that yields identical amplicons from 
every Candida species. We divided the eight species into two groups and 
designed two common and eight species specific primers. The first common 
primer was designed to bind to the 5.8S region of the rDNA complex and 
targeted C. krusei, C. guilliermondii, C. lusitaniae and C. glabrata. The 
second common primer was developed on the basis of sequences of the 18S 
rRNA gene and targeted C. albicans, C. dubliniensis C. tropicalis, and C. 
parpapsilosis sensu lato group. We tested the applicability of the reaction 
with the involvement of 14 reference strains of clinically relevant Candida 
species: C. albicans ATCC 10231, C. lusitaniae CBS 6936, C. krusei CBS 
573, C. inconspicua CBS 180, C. dubliniensis CBS 7987, C. tropicalis CBS 
94, C. norvegensis SZMC 198, C. pulcherrima CBS 5833, C. glabrata CBS 
138, C. parapsilosis CBS 604, C. guilliermondii CBS 566, C. zeylanoides 
CBS 619, C. lipolytica CBS 6124, C. norvegica CBS 4239. Following the 
optimization of the reaction no false positive bands were obtained with any 
of the reference strains. By the optimization of the cycles of the reaction we 
were able to design a nearly one–hour-long PCR. 
Our second aim was to develop a control reaction. Two single copy 
genes, FTR (high affinity iron permease) and PLD (phospholipase D) were 
chosen as targets. The examined part of the FTR gene failed to be suitable 
for the development of a reliable detection system, while the analyzed 
region of the PLD gene allowed us to design species specific primers. We 
were not able to design a control reaction suitable for the detection of all 
species, detected by the previous PCR targeting the rDNA complex. Seven 
of the eight species were identical except C. lusitaniae, and we developed 
specific primer for C. kefyr, which is also an emerging human pathogen. We 
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designed four common primers for C. albicans/C. dubliniensis, C. 
glabrata/C. kefyr, C. tropicalis/C. guilliermodii and C. parapsilosis/C. 
krusei, as well as eight species specific primers. The developed primer sets 
were used dependably for the detection of the eight species in single or 
multiplex PCR. 
We investigated the sensitivity of the reactions using colony PCR. 
A six-step tenfold serial dilution was prepared in distilled water from a 
suspension with a concentration of 108 cells/ml. One μl from each step of 
the dilution was added to each reaction. The sensitivity of the reactions fell 
into the range of 104 and 105 CFU/ml, while in the case of the reaction based 
on the PLD gene it was one step lower (105-106 CFU/ml). 
 
Examination of the genetic variability of C. parapsilosis isolates 
(Kocsubé et al., 2007) 
 
We examined the prevalence and genetic variability of Hungarian 
clinical isolates of C. parapsilosis. The genetic variability of C. parapsilosis 
sensu lato isolates was examined using random amplified polymorphic 
DNA (RAPD) analysis and the sequence analysis of the internal transcribed 
spacer (ITS) region of the rDNA gene cluster. Altogether, 209 Candida 
isolates derived from blood samples from two Hungarian hospitals, located 
in Debrecen and Pécs were examined. Among the previously identified 26 
C. parapsilosis isolates 20 were found to belong to the C. parapsilosis sensu 
lato group using the species-specific primer pair developed by Luo and 
Mitchell (2002). The sequence analysis of the ITS region revealed the 
identity of the rest of the isolates as C. lusitaniae, C. krusei, and C. albicans 
(2, 3 and 1 strains, respectively). RAPD analysis of the isolates was carried 
out by using 21 random decamer primers. The genetic variability observed 
among the isolates was low: the majority of the isolates exhibited highly 
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similar or identical RAPD patterns with most primers tested. Two of the 
isolates showed higher variability compared to the main group, and could 
also be distinguished from other C. parapsilosis isolates using the C. 
parapsilosis group I-specific primer pair, developed by Pontieri et al. 
(2001). According to the ITS sequence analysis the two isolates were 
identified as C. metapsilosis.The two species were also distinguishable by 
the API 20C AUX kit. The C. metapsilosis isolates were found to be able to 
utilize D-xylitol. We examined the antifungal susceptibility profiles of 
isolates belonging to the C. parapsilosis sensu lato group using the Etest 
method. The C. metapsilosis isolates were found to be more susceptible to 
amphotericin B and voriconazole than the C. parapsilosis strains. Among 
the examined isolates 9.6% of Candida infections were found to be caused 
by C. parapsilosis sensu lato in our survey at two Hungarian hospitals. Two 
of these isolates were found to belong to the recently described species C. 
metapsilosis. This is believed to be the first report on the identification of C. 
metapsilosis from bloodstream infection. 
We developed a PCR-based identification method allowing the 
differentiation between the members of the C. parapsilosis sensu lato group. 
The target sequence was the ITS region of the rDNA gene complex. During 
the examination of the sequences of the strains from our culture collection in 
comparison with corresponding sequences from the NCBI GeneBank 
database, we found high variability between C. metapsilosis isolates. Based 
on the differences in the variable ITS1 region the C. metapsilosis isolates 
could be divided into two groups. We developed a PCR-based technique 
specific for the distinct groups. Among the strains in our collection we 
found two isolates belonging to the second group of the C. metapsilosis 
isolates. We examined two further genes, the translation elongation factor 
alpha (TEF1-α) and the 18S rRNA genes. Although the TEF1-α sequences 
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were variable in certain positions none of them were able to distinguish 
reliably between the two groups.  
 
Examination of the in vitro interactions between antifungal agents and 
statins (Nyilasi et al., 2010a,b) 
 
Within the frames of previous studies performed at our Department 
we determined the MIC values of ketoconazole, fluconazole, itraconazole, 
primycin, amphotericin B and nystatin, as well as lovastatin, fluvastatin, 
simvastatin, atorvastatin, rosuvastatin and pravastatin, then carried out also 
the combination tests using Candida albicans ATCC 90028 and C. glabrata 
CBS 138. 
The concentration of ketoconazole needed for the complete 
inhibition appeared to be above 16 μg/ml in the case of C. albicans, while 
100% inhibition of C. glabrata was achieved in the range of 0.5-1 μg/ml. 
The concentration of fluconazole and itraconazole required for the total 
inhibition of the examined C. albicans strain could not be determined either. 
The highest tested concentrations of the compounds were 64 and 16 μg/ml, 
respectively, while for the C. glabrata isolate the MIC values were found to 
be 8-16 and 0.5 μg/ml. Primycin resulted in 100% inhibition of C. albicans 
at a concentration of 64 μg/ml, while it could block the growth of C. 
glabrata entirely at 32 μg/ml. Both isolates were inhibited completely by 
amphotericin B at 1 μg/ml, whereas the concentrations of nystatin needed 
for the 100% inhibition of C. albicans and C. glabrata were shown to be 2 
and 1 μg/ml, respectively. 
Among statins simvastatin and fluvastatin appeared to be the most 
efficient compounds. Simvastatin inhibited C. albicans and C. glabrata 
entirely at 8 and 32 μg/ml, respectively. Fluvastatin was found to cause 
complete inhibition of the examined C. albicans isolate at a concentration of 
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32 μg/ml, while in the case of the C. glabrata strain the 100% inhibition was 
achieved at 64 μg/ml. Atorvastatin and lovastatin were found to block C. 
albicans completely at 128 and 64 μg/ml, respectively, while the 
concentration needed for the total inhibition of C. glabrata was shown to be 
128 μg/ml for both compounds. Rosuvastatin resulted in 100% inhibition of 
both isolates at 128 μg/ml. Pravastatin was found to be the least efficient 
substance among statins as it could not inhibit the examined isolates even in 
the highest concentration (128 μg/ml) tested. 
The examination of the effect of all the possible combinations 
revealed that every antifungal agent had good interacting partners among 
statins. In the case of nystatin and amphotericin B only pravastatin showed 
weak interactions. The antifungal effect of ketoconazole was increased 
significantly by statins on the examined C. albicans and C. glabrata strains. 
In the case of C. albicans only the ketoconazole/pravastatin combination 
was futile. Pravastatin also failed to increase the effect of fluconazole, but 
the other statins appeared to be good interaction partners in the case of both 
strains. The same observation was made in the case of the itraconazole/statin 
combintions. The antifungal effect of primycin was increased to the highest 
degree by simvastatin, fluvastatin and atorvastatin. Due to the interactions 
the concentration needed for the total inhibition of growth decreased by one 
dilution step on average. Based on these observations, we aimed to 
investigate further three Candida species 
We examined the effects of interactions of antifungal agents and 
statins on C. parapsilosis CBS 604, C. guilliermondii CBS 566 and C. 
tropicalis CBS 94 strains. Our aim was to discover effective combinations 
that can be used to treat skin infections caused by Candida species. We 
determined the MIC (Minimal Inhibitory Concentration) values of eight 
antifungal drugs (amphotericin B, ketoconazole, fluconazole, nystatin, 
griseofulvin, itraconazole, primycin, terbinafine) and six statins (lovastatin, 
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simvastatin, fluvastatin, rosuvastatin, atorvastatin, pravastatin) for the three 
species. In the case of C. parapsilosis and C. guilliermondii the most 
effective antifungal agents were ketoconazole and itraconazole, among the 
statins simvastatin and fluvastatin caused the highest inhibition in the 
growth. In the case of C. tropicalis nystatin, itraconazole and primycin 
appeared to be the most effective antifungal drugs. Among the statins, 
simvastatin and fluvastatin were the most efficient. 
Following the determination of the MIC values we examined the 
effects of the interactions between the statins and the antifungal agents using 
checkerboard-titration method 
In the case of the examined C. parapsilosis CBS 604 isolate the 
griseofulvin/statin combinations did not result in interactions. In the 
combination of itraconazole and ketoconazole with statins the antifungal 
agents dominated, antagonistic interactions were not observed. The 
nystatin/statin combinations resulted in a neutral interaction, with the 
dominance of the antifungal agent. The highest number of interactions were 
detected in the terbinafine combinations. The MIC50 values were lowered by 
the statins by one dilution step. In the case of amphotericin B the strongest 
interactions were achieved in the combinations with atorvastatin and 
fluvastatin, while in the case of fluconazole the combination with fluvastatin 
was the most effective. In the combinations of primycin with statins 
fluvastatin and simvastatin were the best interaction partners, but in the case 
of atorvastatin strong antagonism was observed. 
In the case of C. guilliermondii CBS 566, the most effective 
interactions were observed in the itraconazole/statin combinations. 
Simvastatin and atorvastatin lowered the concentration needed for the total 
inhibition of growth by several dilution steps. For amphotericin B the best 
interactions were caused by atorvastatin. In the case of fluconazole 
fluvastatin increased the effect of the antifungal agent the most effectively. 
 11
The inhibition of growth caused by nystatin was not affected by statins 
significantly. The effectiveness of terbinafine was affected mostly by 
lovastatin, simvastatin, fluvastatin and rosuvastatin. These statins lowered 
the terbinafine concentration needed for the 50% inhibition by one dilution 
step. High antagonism was observed in the case of primycin combined with 
simvastatin, fluvastatin and atorvastatin.  
The most significant interactions were observed in the 
combinations tested with the C. tropicalis CBS 94 isolate. The antifungal 
effect of fluconazole, ketoconazole and itraconazole were increased notably 
by almost every statins. The MIC values were lowered by several dilution 
steps. Pravastatin did not affect the MIC values but the MIC50 values were 
lowered by one or two dilution steps. In the case of amphotericin B the most 
effective interaction partners were atorvastatin and rosuvastatin. The 
antifungal effect of griseofulvin was increased by fluvastatin but the total 
inhibition was not achieved. The effect of nystatin and terbinafine was also 
raised by fluvastatin notably. Antagonism was not observed in the 
primycin/statin combinations. The interactions with simvastatin lowered the 
MIC values by one dilution step. Fluvastatin lowered the concentration of 
primycin needed for the complete inhibition by three dilution steps.  
In conclusion, the most effective interaction partner was the 
fluvastatin. The antifungal effect of fluconazole was raised substantially by 
fluvastatin in the experiments carried out with C. parapsilosis CBS 604 and 
C. guilliermondii CBS 566. The effect of amphotericin B was increased 
significantly by atorvastatin on all the examined isolates. The least effective 




Our results can be summarized in the following points: 
1. We developed a PCR-based method for the reliable identification of C. 
krusei, C. guilliermondii, C. lusitaniae, C. glabrata, C. albicans, C. 
dubliniensis C. tropicalis, C. parpapsilosis sensu lato és C. kefyr 
isolates. 
2. We investigated the genetic variability and the frequency of the 
infections caused by Hungarian C. parapsilosis isolates. We developed 
species specific primers for the detection of C. parapsilosis, C. 
orthopsilosis and C. metapsilosis.  
3. We analyzed the susceptibility profiles of C. albicans ATCC 90028, C. 
glabrata CBS 138, C. parapsilosis CBS 604, C. guilliermondii CBS 
566 and C. tropicalis CBS 94 isolates to antifungal agents and statins. 
4. Using the checkerboard-titration method we examined the interactions 
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